LiveWire Ergogenics, Inc.
LVVV · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $4 | $6 | $13 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $4 | $7 | $9 | $15 |
| Revenue | $0 | $2 | $2 | $1 |
| % Growth | -81.4% | -15.7% | 127.7% | – |
| Gross Profit | $0 | $2 | $2 | $1 |
| % Margin | 93.8% | 97.6% | 93.1% | 82.4% |
| EBITDA | $0 | $1 | $1 | -$3 |
| % Margin | 105.9% | 74.4% | 55.1% | -314.6% |
| Net Income | $0 | $1 | $1 | -$3 |
| % Margin | 25.9% | 56.4% | 35.3% | -403.2% |
| EPS Diluted | 0 | 0.001 | 0 | -0.002 |
| % Growth | -100% | 25% | 118.2% | – |
| Operating Cash Flow | $0 | $1 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $1 | $0 | -$0 |